Inflammation, angiogenesis, and endothelial progenitor cells: How do endothelial progenitor cells find their place?

Journal of Molecular and Cellular Cardiology

Volumn 36, Issue 4, 2004, Pages 459-463

  Sata, Masataka ^a   Nagai, Ryozo ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; INTERLEUKIN 1BETA;

ANGIOGENESIS; CELL ACTIVITY; CELL FUNCTION; CELLULAR IMMUNITY; CYTOLOGY; EDITORIAL; ENDOTHELIUM CELL; HUMAN; HUMORAL IMMUNITY; INFLAMMATION; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; STEM CELL;

ANIMALS; BONE MARROW CELLS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; STEM CELLS;

EID: 1842715091     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2004.01.011     Document Type: Editorial

References (46)

1. Folkman J. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. New Engl J Med. 333:1995;1757-1763.
2. Ferrara N. Vascular endothelial growth factor and the regulation of angiogenesis. Recent Prog Horm Res. 55:2000;15-35.
3. Moulton K.S., Vakili K., Zurakowski D., Soliman M., Butterfield C., Sylvin E., et al. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci USA. 100:2003;4736-4741.
4. Moulton K.S., Heller E., Konerding M.A., Flynn E., Palinski W., Folkman J. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation. 99:1999;1726-1732.
5. Luttun A., Tjwa M., Moons L., Wu Y., Angelillo-Scherrer A., Liao F., et al. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med. 8:2002;831-840.
6. Shibuya M. Vascular endothelial growth factor receptor family genes: when did the three genes phylogenetically segregate? Biol Chem. 383:2002;1573-1579.
7. Risau W. Mechanisms of angiogenesis. Nature. 386:1997;671-674.
8. Suri C., Jones P.F., Patan S., Bartunkova S., Maisonpierre P.C., Davis S., et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell. 87:1996;1171-1180.
9. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 275:1997;964-967.
10. Asahara T., Masuda H., Takahashi T., Kalka C., Pastore C., Silver M., et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res. 85:1999;221-228.
11. Sata M., Saiura A., Kunisato A., Tojo A., Okada S., Tokuhisa T., et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med. 8:2002;403-409.
12. Walter D.H., Rittig K., Bahlmann F.H., Kirchmair R., Silver M., Murayama T., et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation. 105:2002;3017-3024.
13. Lagaaij E.L., Cramer-Knijnenburg G.F., van Kemenade F.J., van Es L.A., Bruijn J.A., van Krieken J.H. Endothelial cell chimerism after renal transplantation and vascular rejection. Lancet. 357:2001;33-37.
14. Gunsilius E., Duba H.C., Petzer A.L., Kahler C.M., Grunewald K., Stockhammer G., et al. Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells. Lancet. 355:2000;1688-1691.
15. Tepper O.M., Sealove B.A., Murayama T., Asahara T. Newly emerging concepts in blood vessel growth: recent discovery of endothelial progenitor cells and their function in tissue regeneration. J Invest Med. 51:2003;353-359.
16. Asahara T., Takahashi T., Masuda H., Kalka C., Chen D., Iwaguro H., et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. Embo J. 18:1999;3964-3972.
17. Kalka C., Masuda H., Takahashi T., Gordon R., Tepper O., Gravereaux E., et al. Vascular endothelial growth factor (165) gene transfer augments circulating endothelial progenitor cells in human subjects. Circ Res. 86:2000;1198-1202.
18. Yamaguchi J., Kusano K.F., Masuo O., Kawamoto A., Silver M., Murasawa S., et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation. 107:2003;1322-1328.
19. Wang C., Jiao C., Hanlon H.D., Zheng W., Tomanek R.J., Schatteman G.C. Mechanical, cellular, and molecular factors interact to modulate circulating endothelial cell progenitors. Am J Physiol Heart Circ Physiol. 8:2004;8.
20. Takahashi T., Kalka C., Masuda H., Chen D., Silver M., Kearney M., et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med. 5:1999;434-438.
21. Cho H.J., Kim H.S., Lee M.M., Kim D.H., Yang H.J., Hur J., et al. Mobilized endothelial progenitor cells by granulocyte-macrophage colony-stimulating factor accelerate reendothelialization and reduce vascular inflammation after intravascular radiation. Circulation. 108:2003;2918-2925.
22. Mohle R., Moore M.A., Nachman R.L., Rafii S. Transendothelial migration of CD34+ and mature hematopoietic cells: an in vitro study using a human bone marrow endothelial cell line. Blood. 89:1997;72-80.
23. Heissig B., Hattori K., Dias S., Friedrich M., Ferris B., Hackett N.R., et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell. 109:2002;625-637.
24. Aicher A., Heeschen C., Mildner-Rihm C., Urbich C., Ihling C., Technau-Ihling K., et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med. 9:2003;1370-1376.
25. Vasa M., Fichtlscherer S., Aicher A., Adler K., Urbich C., Martin H., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 89:2001;E1-7.
26. Shintani S., Murohara T., Ikeda H., Ueno T., Honma T., Katoh A., et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation. 103:2001;2776-2779.
27. Gill M., Dias S., Hattori K., Rivera M.L., Hicklin D., Witte L., et al. Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circ Res. 88:2001;167-174.
28. Rauscher F.M., Goldschmidt-Clermont P.J., Davis B.H., Wang T., Gregg D., Ramaswami P., et al. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation. 108:2003;457-463.
29. Edelberg J.M., Tang L., Hattori K., Lyden D., Rafii S. Young adult bone marrow-derived endothelial precursor cells restore aging-impaired cardiac angiogenic function. Circ Res. 90:2002;E89-93.
30. Tepper O.M., Galiano R.D., Capla J.M., Kalka C., Gagne P.J., Jacobowitz G.R., et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation. 106:2002;2781-2786.
31. Vasa M., Fichtlscherer S., Adler K., Aicher A., Martin H., Zeiher A.M., et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation. 103:2001;2885-2890.
32. Dimmeler S., Aicher A., Vasa M., Mildner-Rihm C., Adler K., Tiemann M., et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest. 108:2001;391-397.
33. Llevadot J., Murasawa S., Kureishi Y., Uchida S., Masuda H., Kawamoto A., et al. HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J Clin Invest. 108:2001;399-405.
34. Strehlow K., Werner N., Berweiler J., Link A., Dirnagl U., Priller J., et al. Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation. 107:2003;3059-3065.
35. Fujiyama S., Amano K., Uehira K., Yoshida M., Nishiwaki Y., Nozawa Y., et al. Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells. Circ Res. 93:2003;980-989.
36. Khurana R., Simons M. Endothelial progenitor cells: precursors for angiogenesis. Semin Thorac Cardiovasc Surg. 15:2003;250-258.
37. Amano K., Okigaki M., Adachi Y., Fujiyama S., Mori Y., Kosaki A., et al. Mechanism for IL-1β-mediated neovascularization unmasked by IL-1β knock-out mice. J Mol Cell Cardiol. 36: 2004;. next article in this issue.
38. Hill J.M., Zalos G., Halcox J.P., Schenke W.H., Waclawiw M.A., Quyyumi A.A., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. New Engl J Med. 348:2003;593-600.
39. Simper D., Stalboerger P.G., Panetta C.J., Wang S., Caplice N.M. Smooth muscle progenitor cells in human blood. Circulation. 106:2002;1199-1204.
40. Gulati R., Jevremovic D., Peterson T.E., Witt T.A., Kleppe L.S., Mueske C.S., et al. Autologous culture-modified mononuclear cells confer vascular protection after arterial injury. Circulation. 108:2003;1520-1526.
41. Urbich C., Heeschen C., Aicher A., Dernbach E., Zeiher A.M., Dimmeler S. Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation. 108:2003;2511-2516.
42. Reyes M., Dudek A., Jahagirdar B., Koodie L., Marker P.H., Verfaillie C.M. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest. 109:2002;337-346.
43. Folkman J. Clinical-applications of research on angiogenesis. New Engl J Med. 333:1995;1757-1763.
44. Freedman S., Isner J.M. Therapeutic angiogenesis for ischemic cardiovascular disease. J Mol Cell Cardiol. 33:2001;379-393.
45. Hu Y., Davison F., Zhang Z., Xu Q. Endothelial replacement and angiogenesis in arteriosclerotic lesions of allografts are contributed by circulating progenitor cells. Circulation. 108:2003;3122-3127.
46. Saiura A., Sata M., Hirata Y., Nagai R., Makuuchi M. Circulating smooth muscle progenitor cells contribute to atherosclerosis. Nat Med. 7:2001;382-383.